# Normoxic Challenges Utility to Evaluate Blood Loss

> **NCT03194581** · — · TERMINATED · sponsor: **Centro Hospitalar do Tâmega e Sousa** · enrollment: 10 (actual)

## Conditions studied

- Hemorrhage

## Interventions

- **DEVICE:** Cerebral oxygenation

## Key facts

- **NCT ID:** NCT03194581
- **Lead sponsor:** Centro Hospitalar do Tâmega e Sousa
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2017-10-01
- **Primary completion:** 2018-09-30
- **Final completion:** 2018-09-30
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Profissional reasons, not related with the study
- **Last updated:** 2022-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03194581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03194581, "Normoxic Challenges Utility to Evaluate Blood Loss". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03194581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*